Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Jan 08, 2024 7:23pm
231 Views
Post# 35816618

RE:RE:RE:RE:RE:RE:RE:Billion dollar deal

RE:RE:RE:RE:RE:RE:RE:Billion dollar dealHang in there palinc2000!  I am too.  I get super tired of reading the majority of these posts as well.  I'm hanging on by a thread and have lost all confidence, but I see no point in belaboring the point.  We still have cash flowing assets and a pipeline of potential.  It appears we need divine intervention to get anything moving in our favor, but we still have a fleeting chance of something good coming from all of this.

palinc2000 wrote:

not see a Major retracement

palinc2000 wrote:

I am getting so sick of reading constant day after day  negativity ,predictions of doom and gloom etc not from you but I might have over reacted at your comment
The last FDA approval was for IV Push for Trogarzo the significance of which was negligible .... IM for Trog will/ should have much more positive impact...

The next Pdufa date in about 2 weeks  for F8  formulation is much much more significant imo and  if approved which I assume it will we   will not see a retracement  ,Hard to know exactly who are the Buyers but I do think the fundamentalists are the majority....I may be wrong of course but I think the past is water under the bridge ..... 
Happy New Year
 

PWIB123 wrote: It's super simple palinc2000.  You are astute, and I'm surprised you fail to see the pertinance here.  There are traders who simply buy drug companies with upcoming PDFU dates.  These traders are looking for a quick flip and nothing more.  The last time one of these dates was posted regarding THTX, there was a lot of online chatter.  There's much less this time, but the chatter is still there, and I imagine some algo has picked it up.  I hope there's something much more fundamental at play here, but history tends to repeat itself.  Thus the comment about the decline in share price.  Hopefully it's something else driving share price, but the timing cannot be ignored.  We need something more than a few new traders looking at a PDFU date.

palinc2000 wrote:

F8 could be a game changer if it is the trigger to go ahead in Nash with a partner which is more or less what Levesque had been claiming .
I fail to see the pertinence of your comment on  the decline in the SP increase the last time.. Different circumstances all together .....It is undeniable imo that the Market Cap


PWIB123 wrote: Could it be that this PDFU date is actually driving the share price increase?  It happened last time, and the share price lost more than 100% of the increase after the fact.  

https://www.fdatracker.com/fda-calendar/

 




 


 



<< Previous
Bullboard Posts
Next >>